Why “underpowered” trials are not necessarily unethical

[1]  C H Schmid,et al.  Large trials vs meta-analysis of smaller trials : How do their results compare ? , 1996 .

[2]  M. Hlatky,et al.  Growing pains of meta-analysis , 1996, BMJ.

[3]  R J Lilford,et al.  For Debate: The statistical basis of public policy: a paradigm shift is overdue , 1996, BMJ.

[4]  J. Thornton,et al.  Preterm breech babies and randomised trials of rare conditions , 1996, British journal of obstetrics and gynaecology.

[5]  M. Baum,et al.  Ethics of clinical trials: the ‘forbidden fruit’ phenomena , 1996 .

[6]  J G Thornton,et al.  Clinical trials and rare diseases: a way out of a conundrum , 1995, BMJ.

[7]  R J Lilford,et al.  Equipoise and the ethics of randomization. , 1995, Journal of the Royal Society of Medicine.

[8]  P. Fayers,et al.  Sample size: how many patients are necessary? , 1995, British Journal of Cancer.

[9]  R. J. Hayes,et al.  Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. , 1995, JAMA.

[10]  A Liberati,et al.  "Meta-analysis: statistical alchemy for the 21st century": discussion. A plea for a more balanced view of meta-analysis and systematic overviews of the effect of health care interventions. , 1995, Journal of clinical epidemiology.

[11]  S. Goodman,et al.  The Use of Predicted Confidence Intervals When Planning Experiments and the Misuse of Power When Interpreting Results , 1994, Annals of Internal Medicine.

[12]  P. Freeman,et al.  The role of p-values in analysing trial results. , 1993, Statistics in medicine.

[13]  M. Parmar,et al.  Meta-analysis of the literature or of individual patient data: is there a difference? , 1993, The Lancet.

[14]  P. Fayers,et al.  Towards an international register of cancer trials: the UKCCCR register of U.K. trials. , 1993, European journal of cancer.

[15]  F. Mosteller,et al.  A comparison of results of meta-analyses of randomized control trials and recommendations of clinical experts. Treatments for myocardial infarction. , 1992, JAMA.

[16]  C D Naylor,et al.  Incorporating variations in the quality of individual randomized trials into meta-analysis. , 1992, Journal of clinical epidemiology.

[17]  S. Pocock,et al.  Can meta-analyses be trusted? , 1991, The Lancet.

[18]  G. Barnard.  Must clinical trials be large? The interpretation of P-values and the combination of test results. , 1990, Statistics in medicine.

[19]  R. Lilford,et al.  The alpha and beta errors in randomized trials. , 1990, The New England journal of medicine.

[20]  R. Lilford,et al.  Size of trials for evaluation of antenatal tests of fetal wellbeing in high risk pregnancy , 1990, Journal of perinatal medicine.

[21]  R. Lilford.  Evaluating New Treatments and Diagnostic Technologies in Obstetrics: Practical Problems, Ethics, and Solutions , 1989, International Journal of Technology Assessment in Health Care.

[22]  L. Freedman,et al.  The size of clinical trials in cancer research--what are the current needs? Medical Research Council Cancer Therapy Committee. , 1989, British Journal of Cancer.

[23]  D. Clayton,et al.  Ethically optimised designs. , 1982, British journal of clinical pharmacology.

[24]  D. Altman.  Statistics and ethics in medical research: III How large a sample? , 1980, British medical journal.